German independent research institute BioMed X announces the successful completion of its oncology research project in partnership with Merck. The data generated by this project has been acquired by ...

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, announces the appointment of Dr. Klaus Edvardsen as its new Chief Medical ...

Sanofi announced its intention to execute a share buyback program in 2025 of €5 billion, preferably through block trades and in the open market with the purpose of cancellation. A first tranche of ...

Pioneer Group, a leader in life science infrastructure and venture-building, has appointed industry leader, Chris Walters, as Portfolio Director and European Acquisitions Lead. Chris brings extensive ...

Clinigen, the global speciality pharmaceutical services group, and Essential Pharma, an international specialty pharmaceutical group, today announced an expansion of their JAPAC collaboration, aimed ...

Actimed Therapeutics, a UK based clinical stage speciality pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, announces today ...

Syncona Ltd (”Syncona”), a leading life science investor focused on creating, building and scaling a portfolio of global leaders in life science, today issues its quarterly update covering the period ...

Researchers have created a remarkable new map of a key part of our brain, the hypothalamus, that will lead to new ways of controlling our weight, appetite, sleep and stress levels. Health and wellness ...

In an industry-defining moment, Accumulus Synergy (“Accumulus”) has powered Amgen’s groundbreaking regulatory submission: the first-ever, digitally generated Chemistry, Manufacturing, and Controls ...

VANCOUVER, BC / ACCESS Newswire / February 6, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, ...

SALT LAKE CITY, UTAH / ACCESS Newswire / February 6, 2025 / CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals' ...

TORONTO, ONTARIO / ACCESS Newswire / February 6, 2025 / Smile CDR Inc. (d.b.a. Smile Digital Health), the world leader in FHIR®-based health data solutions, today announced a successful $15 million ...